Slide 1 Roscoe Brady, M.D. Scientist Emeritus National Institutes of Health Bethesda, Maryland USA Slide 2 CURRENT APPROACHES TO TREAT PATIENTS WITH HEREDITARY METABOLIC…
Slide 1 Movex@Actelion Slide 2 2 June 14 2010 Actelion, a short portrait Migration to M3: Background History of M3 at Actelion System outsourcing Lessons learned Success…
Slide 1 M. di Gaucher e M.di Parkinson: quale relazione Bruno Bembi Centro di Coordinamento Regionale per le Malattie Rare Ospedale Universitario di Udine 55° CONGRESSO…
Slide 1 By Stephen Monahan Slide 2 Genes on chromosome 3 include ABHD5,ALAS1, AMT,ATP2B2, and BCHE Chromosome 3 contains between 1,100 to 1,500 genes where ABHD5,ALAS1,…
Presentación de PowerPoint The ZAGAL Study: Long-term Management and Follow-up of use of Miglustat in type 1 Gaucher disease in Spain. Pilar Giraldo Haematology Department.…
Impact of Velaglucerase Alfa Therapy on Bone Marrow Burden Score in Adults with Type 1 Gaucher Disease: 7-Year Experience Deborah Elstein;1 Andrew H. Haims;2 David Zahrieh;3…
Presentación de PowerPoint The ZAGAL Study: Long-term Management and Follow-up of use of Miglustat in type 1 Gaucher disease in Spain. Pilar Giraldo Haematology Department.…
PowerPoint Presentation Roscoe Brady, M.D. Scientist Emeritus National Institutes of Health Bethesda, Maryland USA CURRENT APPROACHES TO TREAT PATIENTS WITH HEREDITARY METABOLIC…
Whole body MRI technique in early treated non-neuronopathic patients with enzyme replacement therapy at least eight years Whole body MRI technique in early treated non-neuronopathic…